Navigating Access to Cancer Care: Identifying Barriers to Precision Cancer Medicine.

Precision medicine is revolutionizing cancer treatment. Our combined analyses suggest that both system-level and patient-level barriers limit patient access to precision cancer medicine options.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 However, there has been limited investigation of barriers patients endure to access precision cancer medicine.
• 2 This study aims to report the experiences of underserved patient populations with limited access to genomic testing, clinical trials, and precision cancer treatment.
• 3 A mixed-method study was employed to quantitatively evaluate patients (N=300) seeking precision cancer medicine between January 2014- August 2017.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: